Literature DB >> 17002541

Antibacterial use and Streptococcus pneumoniae penicillin resistance: A temporal relationship model.

Robertino M Mera1, Linda A Miller, Anthony White.   

Abstract

The nature of the temporal relationship between antibacterial consumption and Streptococcus pneumoniae penicillin resistance is investigated using population level data across time. IMS Health Global Services provided national outpatient antibiotic prescription data for the years 1996-2003 from France, Spain, Italy, Germany, the United Kingdom, and the United States. Surveillance data consist of S. pneumoniae isolates obtained from a surveillance database in the same geographic regions from 1996 to 2003. A linear mixed model for repeated measures was used to analyze the association between resistance and several antibacterial classes through time. Changes in penicillin resistance through time in any country are better explained by the weighted cumulative antibacterial consumption with a 2-year lag. Narrow-spectrum penicillins are associated with lower resistance rates. Large reductions in consumption at the population level are needed to affect resistance. There is a peak level of penicillin resistance associated with cumulative exposure to a combination of antibiotic classes that is unique for every country.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17002541     DOI: 10.1089/mdr.2006.12.158

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  5 in total

Review 1.  Antibiotic use and population ecology: how you can reduce your "resistance footprint".

Authors:  David M Patrick; James Hutchinson
Journal:  CMAJ       Date:  2009-02-17       Impact factor: 8.262

2.  Patterns of antibacterial use and impact of age, race/ethnicity, and geographic region on antibacterial use in an outpatient medicaid cohort.

Authors:  Alice M Gahbauer; Marco L Gonzales; B Joseph Guglielmo
Journal:  Pharmacotherapy       Date:  2014-04-19       Impact factor: 4.705

3.  Reporting Emerging Resistance of Streptococcus pneumoniae from India.

Authors:  Kiran Chawla; Bimala Gurung; Chiranjay Mukhopadhyay; Indira Bairy
Journal:  J Glob Infect Dis       Date:  2010-01

4.  Risk factors for development of multiple-class resistance to Streptococcus pneumoniae Strains in Belgium over a 10-year period: antimicrobial consumption, population density, and geographic location.

Authors:  Johan Van Eldere; Robertino M Mera; Linda A Miller; James A Poupard; Heather Amrine-Madsen
Journal:  Antimicrob Agents Chemother       Date:  2007-08-06       Impact factor: 5.191

5.  Antibiotic selection pressure and macrolide resistance in nasopharyngeal Streptococcus pneumoniae: a cluster-randomized clinical trial.

Authors:  Alison H Skalet; Vicky Cevallos; Berhan Ayele; Teshome Gebre; Zhaoxia Zhou; James H Jorgensen; Mulat Zerihun; Dereje Habte; Yared Assefa; Paul M Emerson; Bruce D Gaynor; Travis C Porco; Thomas M Lietman; Jeremy D Keenan
Journal:  PLoS Med       Date:  2010-12-14       Impact factor: 11.069

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.